Increased forearm bone mineral content after bromocriptine treatment in hyperprolactinemia.
作者信息
Caraceni M P, Corghi E, Ortolani S, Casazza S, D'Alberton A, Motta T
出版信息
Calcif Tissue Int. 1985 Dec;37(6):687-9. doi: 10.1007/BF02554932.
PMID:3937596
Abstract
We studied 15 hyperprolactinemic women to evaluate possible modifications of bone mineral content after pharmacological treatment. Patients received a dopamine agonist (bromocriptine) for six months after which there was a significant decrease of prolactin plasma levels (P less than 0.01) and a significant increase of bone mineral content (P less than 0.05).
摘要
Zotero 插件